0001437749-22-013129.txt : 20220519 0001437749-22-013129.hdr.sgml : 20220519 20220519204011 ACCESSION NUMBER: 0001437749-22-013129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220517 FILED AS OF DATE: 20220519 DATE AS OF CHANGE: 20220519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buller Richard E CENTRAL INDEX KEY: 0001688319 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38207 FILM NUMBER: 22945007 MAIL ADDRESS: STREET 1: C/O CELCUITY INC. STREET 2: 16305 36TH AVE. N., #100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celcuity Inc. CENTRAL INDEX KEY: 0001603454 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 BUSINESS PHONE: 763-392-0767 MAIL ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 FORMER COMPANY: FORMER CONFORMED NAME: Celcuity LLC DATE OF NAME CHANGE: 20140324 4 1 rdgdoc.xml FORM 4 X0306 4 2022-05-17 0001603454 Celcuity Inc. CELC 0001688319 Buller Richard E 16305 36TH AVENUE NORTH SUITE 100 MINNEAPOLIS MN 55446 1 Common Stock 2022-05-17 4 A 0 3273 0 A 11798 D Stock Option (right to buy) 10.68 2022-05-17 4 D 0 4555 D 2029-12-03 Common Stock 4555 0 D Stock Option (right to buy) 5.50 2022-05-17 4 A 0 4555 A 2029-12-03 Common Stock 4555 4555 D Stock Option (right to buy) 26.99 2022-05-17 4 D 0 2310 D 2031-05-12 Common Stock 2310 0 D Stock Option (right to buy) 5.50 2022-05-17 4 A 0 2310 A 2031-05-12 Common Stock 2310 2310 D Stock Option (right to buy) 5.1000 2030-05-14 Common Stock 12654 12654 D Stock Option (right to buy) 5.50 2022-05-17 4 A 0 19558 0 A 2032-05-17 Common Stock 19558 19558 D Represents 3,273 shares of restricted stock for which risks of forfeiture lapse on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. 100% vested. This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. /s/ Eric O. Madson as Attorney-in-Fact for Richard E. Buller pursuant to Power of Attorney previously filed. 2022-05-19